With effect from 11 June 2018
Sterling Biotech announced the initiation of Corporate Insolvency Resolution Process by NCLT with effect from 11 June 2018. Sundaresh Bhat has been appointed as the Interim Resolution Professional and as such the powers of the board are suspended and shall be exercised by the IRP.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
